Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Houé

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Emerging Microbes & Infections|April 3, 2019
Endogenous non-retroviral elements in genomes of Aedes mosquitoes and vector competenceVincent Houé, Mariangela Bonizzoni, Anna-Bella Failloux
Nucleic Acids Research|January 3, 2018
Contrasting silencing mechanisms of the same target mRNA by two regulatory RNAs in Escherichia coliDavid Lalaouna, Karine Prévost, Guillaume Laliberté, et al.
Plos Neglected Tropical Diseases|July 19, 2018
Combining Wolbachia-induced sterility and virus protection to fight Aedes albopictus-borne virusesRiccardo Moretti, Pei-Shi Yen, Vincent Houé, et al.
Viruses|April 3, 2021
Profile of Small RNAs, vDNA Forms and Viral Integrations in Late Chikungunya Virus Infection of <i>Aedes albopictus</i> MosquitoesMichele Marconcini, Elisa Pischedda, Vincent Houé, et al.
Emerging Microbes & Infections|August 31, 2019
Evolution and biological significance of flaviviral elements in the genome of the arboviral vector <i>Aedes albopictus</i>Vincent Houé, Gaelle Gabiane, Catherine Dauga, et al.
Plos Neglected Tropical Diseases|December 3, 2019
Polymorphism analyses and protein modelling inform on functional specialization of Piwi clade genes in the arboviral vector Aedes albopictusMichele Marconcini, Luis Hernandez, Giuseppe Iovino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2015
Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC--A Randomized Phase III TrialJ Randolph Hecht, Yung-Jue Bang, Shukui K Qin, et al.
The Lancet. Oncology|December 19, 2012
Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trialJohn R Mackey, Miguel Martin, Tadeusz Pienkowski, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Emerging Microbes & Infections|April 3, 2019
Endogenous non-retroviral elements in genomes of Aedes mosquitoes and vector competenceVincent Houé, Mariangela Bonizzoni, Anna-Bella Failloux
Nucleic Acids Research|January 3, 2018
Contrasting silencing mechanisms of the same target mRNA by two regulatory RNAs in Escherichia coliDavid Lalaouna, Karine Prévost, Guillaume Laliberté, et al.
Plos Neglected Tropical Diseases|July 19, 2018
Combining Wolbachia-induced sterility and virus protection to fight Aedes albopictus-borne virusesRiccardo Moretti, Pei-Shi Yen, Vincent Houé, et al.
Viruses|April 3, 2021
Profile of Small RNAs, vDNA Forms and Viral Integrations in Late Chikungunya Virus Infection of <i>Aedes albopictus</i> MosquitoesMichele Marconcini, Elisa Pischedda, Vincent Houé, et al.
Emerging Microbes & Infections|August 31, 2019
Evolution and biological significance of flaviviral elements in the genome of the arboviral vector <i>Aedes albopictus</i>Vincent Houé, Gaelle Gabiane, Catherine Dauga, et al.
Plos Neglected Tropical Diseases|December 3, 2019
Polymorphism analyses and protein modelling inform on functional specialization of Piwi clade genes in the arboviral vector Aedes albopictusMichele Marconcini, Luis Hernandez, Giuseppe Iovino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2015
Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC--A Randomized Phase III TrialJ Randolph Hecht, Yung-Jue Bang, Shukui K Qin, et al.
The Lancet. Oncology|December 19, 2012
Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trialJohn R Mackey, Miguel Martin, Tadeusz Pienkowski, et al.
Pageof 1